Did You Know...
...that Charles Goodyear performed some of his experiments on rubber while in debtor's prison? He was there so often he referred to it as his "hotel". Chronically in debt because of poor business sense and ill health, Goodyear depended on the generosity of friends and family. Even after he unlocked the secret to vulcanizing rubber, he was unable to improve his financial situation. When he died, his estate was $200,000 in debt.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 4432750 | Additive sterol solution and method for preserving normal red cell morphology in whole blood during storage An additive solution is used to preserve normal red blood cell morphology during storage. The solution comprises a concentration of a nontoxic, physiologically compatible sterol, such as cholesterol, epi-cholesterol, lanosterol, stigmasterol, ergosterol, ... | 02/21/1984 |
| 4428934 | Method for oxygenating blood A rigid blood oxygenator in which blood and oxygen-rich gas are admitted at the top of the device and caused to flow substantially concurrently downwardly through a tortuous path. During the course of this downward flow, oxygen-rich gas bubbles are formed... | 01/31/1984 |
| 4375509 | Anti-hemolytic agent emulsions Blood may be stored in vitro for a period of days at a reduced temperature in the container which also includes a sufficient quantity of an emulsion of anti-hemolytic agent to cause a reduction in the hemolysis of the stored blood, when compared with bloo... | 03/01/1983 |
| 4373023 | Process for neutralizing heparin Blood containing heparin and treated extracorporeally is contacted with immobilized heparinase prior to being reintroduced into the patient.... | 02/08/1983 |
| 4359463 | Stabilization of Factor VIII activity in whole blood or blood plasma A method whereby initial Factor VIII activity normally present in blood collected into an anticoagulant which functions by chelating calcium is maintained for twenty-four or more hours without the necessity of the usual immediate freezing in either the wh... | 11/16/1982 |
| 4357321 | Method and composition for treating clotting factor inhibitors A composition comprising about from 37 to 190 units of factor VII/ml and about from 25 to 80 units of factor VIIa/ml is administered to patients in the treatment of clotting factor inhibitors. The composition may include activated and unactivated clotting... | 11/02/1982 |
| 4326025 | Anti-hemolytic agent emulsions and the use thereof Blood may be stored in vitro for a period of days at a reduced temperature in the container which also includes a sufficient quantity of an emulsion of anti-hemolytic agent to cause a reduction in the hemolysis of the stored blood, when compared with bloo... | 04/20/1982 |
| 4322313 | Stabilized multi-purpose blood diluent A multi-purpose blood diluent for blood cells for use in electronic counting and sizing of blood cells comprising a stable water solution of chemical salts providing an electrolytic solution to which a blood sample can be added to dilute the large number ... | 03/30/1982 |
| 4301153 | Heparin preparation A heparin preparation which exhibits elevated anticoagulant activity and a process for producing the preparation. Conventional heparin exhibiting characteristic anticoagulant activity and molecular heterogeneity is incubated with antithrombin-heparin cofa... | 11/17/1981 |
| 4299726 | Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor A process for preparing whole blood reference controls having long term stability up to six months for devices using electronic means for whole blood determinations including platelet count and mean cell volume and red blood distribution width. The precon... | 11/10/1981 |
| 4282375 | Halogenated-naphthalenetriyltris(sulfonylimino)-aryl multicarboxylic acids and salts thereof Halogenated-naphthalenetriyltris(sulfonylimino)-aryl multicarboxylic acids and salts thereof useful as complement inhibitors.... | 08/04/1981 |
| 4269826 | Physiological preparation containing loaded cells in suspension and a magnetic agent for local concentration thereof in a living body Magnetic substances in particles of a diameter in the range between 1 and 20 nm are suspended in the physiological solution by which cells are loaded with materials when their cell membranes have increased permeability, the magnetic materials being provid... | 05/26/1981 |
| 4266077 | Naphthalenetetrayltetrakis(sulfonylimino)-aryl multicarboxylic acids and salts thereof Naphthalenetetrayltetrakis(sulfonylimino)-aryl multicarboxylic acids and salts thereof useful as complement inhibitors.... | 05/05/1981 |
| 4221780 | Method for producing high potency factor VIII Factor VIII preparations of enhanced potency are obtained from human blood donors by recovering blood from donors who have been treated with 1-deamino-8-D-arginine vasopressin, in an amount sufficient to increase the circulating blood level of Factor VIII... | 09/09/1980 |
| 4210634 | Growth promoting fish food composition The rate at which conventional fish food is converted to body protein by a wide variety of growing fish is increased substantially when the food contains 0.05 to 0.5% by weight, on a dry basis, of an extract from the blood or an organ of a vertebrate anim... | 07/01/1980 |
| 4206077 | Agent for facilitating the counting of thrombocytes in blood samples An agent for facilitating the counting of thrombocytes in blood samples in the presence of erythrocytes, comprises an aqueous solution of mercuric chloride in a concentration of between 1.2 and 4.0 g/l. The pH of this solution is adjusted to 1.5 to 4.8, p... | 06/03/1980 |
| 4199022 | Method of freezing living cells and tissues with improved subsequent survival This invention relates to an improved method for freezing red blood cells, ther living cells, or tissues with improved subsequent survival, wherein constant-volume freezing is utilized that results in significantly improved survival compared with constant-... | 04/22/1980 |
| 4177261 | Pharmaceutical composition and method of stimulating blood circulation and wound healing There is disclosed a pharmaceutical composition useful in stimulating blood circulation and healing of wounds. This composition comprises (a) albumin-freed calf blood extract, and (b) from about 0.001 to about 2.5 micrograms of at least one kinin per mill... | 12/04/1979 |
| 4124992 | Method and apparatus for the deep cooling of liquid biological substances A system for preparing liquid biological substances, such as blood, blood components or cell suspensions for deep freezing which comprises atomizing a protective additive and dripping the biological substance into the stream of the atomized protective sub... | 11/14/1978 |
| 4116635 | General purpose in vitro anticoagulant A process for testing a blood sample as for coagulation, hematology, chemistries, enzymes, electrolytes and trace metals which involves the addition of a particular anticoagulant. The anticoagulant is a calcium chelating agent having a Log K' of from abou... | 09/26/1978 |
| 4096244 | Immunoglobulins for administration to piglets Immunoglobulins for new-born piglets to provide them with antibodies effective against disease are administered as a dried particulate serum obtained from animal blood and having a reduced sodium chloride content. Such a serum is palatable to piglets and ... | 06/20/1978 |
| 4076701 | Tumor complement fraction recovery method and product A process is provided for the isolation of a blood polypeptide fraction or derivatives thereof herein termed the "tumor complement fraction" or "TCF", from mammalian blood. The process comprises a series of centrifugal separations of blood fractions under... | 02/28/1978 |
| 4059512 | Process for removing endotoxin from biological fluids A novel process for removing endotoxin from biological fluids such as parenteral fluids and for removing or reducing the level of endotoxin from the blood of animals is disclosed. The novel process includes the utilization of certain non-ionogenic hydroph... | 11/22/1977 |
| 4004322 | Aseptic serum collection method A method for aseptically collecting blood from an animal carcass, preferably, a fetus. The method includes pooling blood from the placenta and umbilical cord into the cardiovascular system of the fetus and thereafter draining the blood from the fetus. The... | 01/25/1977 |
| 3973001 | Tissue cell stimulating blood extracts Novel blood extracts of vertebrata, i.e. animals having a vertebral column, especially warm blooded animals, which blood extracts possess cell respiration stimulating activity and stimulate the growth of cells and to novel processes for the preparation of... | 08/03/1976 |
| 3932618 | Anti-inflammatory compositions An anti-inflammatory composition comprises an anti-inflammatorily effective amount of a reaction product of a blood with a protease.... | 01/13/1976 |
